Medical Burden of Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Infection Among US Children: Implications for Design of Vaccine Trials
Human Vaccines · 2005
DOI: 10.4161/hv.1.1.1424 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Vaccines, 2005. Verfasst von Min-Shi Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: MedImmune Vaccines Inc., Mountain View, California, USA. mslee007@us.sina.com. Hauptthemen laut MEDLINE: Parainfluenza Virus 3, Human, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 44-mal zitiert (Crossref).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MedImmune Vaccines Inc., Mountain View, California, USA. mslee007@us.sina.com
Zitieren
APA
Lee, M. S., Walker, R. E., & Mendelman, P. M. (2005). Medical Burden of Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Infection Among US Children: Implications for Design of Vaccine Trials. Human Vaccines. https://doi.org/10.4161/hv.1.1.1424
Vancouver
Lee MS, Walker RE, Mendelman PM. Medical Burden of Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Infection Among US Children: Implications for Design of Vaccine Trials. Human Vaccines. 2005. doi:10.4161/hv.1.1.1424
BibTeX
@article{Lee2005,
author = {Lee, Min-Shi and Walker, Robert E and Mendelman, Paul M},
title = {Medical Burden of Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Infection Among US Children: Implications for Design of Vaccine Trials},
journal = {Human Vaccines},
year = {2005},
doi = {10.4161/hv.1.1.1424}
}
EUVIMED